RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Luis M. Vilá has written about Angiotensin-Converting Enzyme Inhibitors.
Luis M. Vilá
Connection Strength
0.070
Angiotensin-Converting Enzyme Inhibitors
  1. Dur?n-Barrag?n S, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford). 2008 Jul; 47(7):1093-6.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support